CRS members receive a discounted subscription -
Join CRS today!
The Journal of Controlled Release has a current impact factor of 7.633, making it one of the most influential journals in the pharmaceutics, biomaterials, and drug delivery fields.
The journal publishes innovative, original research involving the controlled release and delivery of drugs and other biologically active agents. The terms "controlled release" and "delivery" are used in their broadest sense to include mechanisms such as diffusion, chemical and enzymatic reactions, dissolution, osmosis, targeting, as well as the utilization and manipulation of biological processes. A broad spectrum of studies dealing with all aspects of controlled release and delivery, including gene delivery, tissue engineering and diagnostic agents, is encouraged. The use of prodrugs and carriers such as water-soluble polymers, micro and nanoparticles, liposomes and micelles is included in the scope.
In addition to original full length papers and reviews, the journal includes reports of future meetings and announcements pertaining to the activities of the Controlled Release Society.
CRS member subscribers can access The Journal of Controlled Release at:
Editor-in-Chief: Kinam Park, Purdue University, USA